• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉芽肿性多血管炎(GPA)中的垂体垂体炎:病例系列。

Pituitary hypophysitis in granulomatosis with polyangiitis (GPA): a case series.

机构信息

Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

Department of Radiology, Imperial College Healthcare NHS Trust, London, UK.

出版信息

Pituitary. 2024 Apr;27(2):230-237. doi: 10.1007/s11102-023-01378-5. Epub 2024 Jan 31.

DOI:10.1007/s11102-023-01378-5
PMID:38296897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11009729/
Abstract

Granulomatosis with polyangiitis (GPA) rarely involves the pituitary gland. Pituitary involvement has been reported in ~ 1% of all cases of GPA. Most commonly, pituitary swelling and inflammation results in symptoms due to pituitary mass effect and arginine vasopressin deficiency. To date, there are no pituitary-specific treatment guidelines for this rare condition. We present three patients with GPA-related hypophysitis highlighting the spectrum of pituitary involvement. All three patients were successfully treated with immunosuppressive regimens that included rituximab (RTX). Following remission induction with high-dose glucocorticoids, patients received 6 monthly RTX for remission maintenance. RTX was well tolerated without significant side effects.

摘要

肉芽肿性多血管炎(GPA)很少累及垂体。据报道,在 GPA 的所有病例中,约有 1%累及垂体。最常见的是,垂体肿胀和炎症导致因垂体肿块效应和精氨酸加压素缺乏而出现症状。迄今为止,针对这种罕见疾病,尚无专门的垂体治疗指南。我们介绍了 3 例 GPA 相关的垂体炎患者,重点阐述了垂体受累的范围。所有 3 例患者均成功接受了免疫抑制治疗方案,包括利妥昔单抗(RTX)。在大剂量糖皮质激素诱导缓解后,患者接受 6 个月的 RTX 以维持缓解。RTX 耐受性良好,无明显副作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/674e/11009729/b8d2bdcb76b1/11102_2023_1378_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/674e/11009729/8732bb1a4471/11102_2023_1378_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/674e/11009729/32824c34a236/11102_2023_1378_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/674e/11009729/b8d2bdcb76b1/11102_2023_1378_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/674e/11009729/8732bb1a4471/11102_2023_1378_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/674e/11009729/32824c34a236/11102_2023_1378_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/674e/11009729/b8d2bdcb76b1/11102_2023_1378_Fig3_HTML.jpg

相似文献

1
Pituitary hypophysitis in granulomatosis with polyangiitis (GPA): a case series.肉芽肿性多血管炎(GPA)中的垂体垂体炎:病例系列。
Pituitary. 2024 Apr;27(2):230-237. doi: 10.1007/s11102-023-01378-5. Epub 2024 Jan 31.
2
Pituitary dysfunction in granulomatosis with polyangiitis.肉芽肿性多血管炎的垂体功能障碍。
Clin Rheumatol. 2020 Feb;39(2):595-606. doi: 10.1007/s10067-019-04735-7. Epub 2019 Aug 24.
3
Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients.利妥昔单抗诱导和维持治疗肉芽肿性多血管炎:一项单中心 114 例患者的队列研究。
Rheumatology (Oxford). 2019 Mar 1;58(3):401-409. doi: 10.1093/rheumatology/key117.
4
Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.利妥昔单抗诱导和维持治疗肉芽肿性多血管炎(韦格纳氏)。一项单中心队列研究 66 例患者的结果。
J Autoimmun. 2014 May;50:135-41. doi: 10.1016/j.jaut.2014.03.002. Epub 2014 Apr 2.
5
Pituitary involvement in patients with granulomatosis with polyangiitis: case series and literature review.肉芽肿性多血管炎患者的垂体受累:病例系列及文献复习。
Rheumatol Int. 2019 Aug;39(8):1467-1476. doi: 10.1007/s00296-019-04338-0. Epub 2019 Jun 15.
6
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.利妥昔单抗作为常规免疫抑制治疗抵抗的嗜酸性肉芽肿伴多血管炎的诱导治疗:36 个月随访分析。
J Allergy Clin Immunol Pract. 2017 Nov-Dec;5(6):1556-1563. doi: 10.1016/j.jaip.2017.07.027. Epub 2017 Sep 12.
7
Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.评估利妥昔单抗治疗儿童肉芽肿性多血管炎或显微镜下多血管炎的 IIa 期全球研究。
Arthritis Rheumatol. 2022 Jan;74(1):124-133. doi: 10.1002/art.41901. Epub 2021 Dec 5.
8
Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).利妥昔单抗治疗肉芽肿性多血管炎(韦格纳氏)患者的难治性巩膜炎
Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2279-84. doi: 10.1007/s00417-015-3198-5. Epub 2015 Oct 27.
9
Hypophysitis in granulomatosis with polyangiitis: rare presentation of a multisystem disease.肉芽肿性多血管炎伴发的垂体炎:一种多系统疾病的罕见表现。
J R Coll Physicians Edinb. 2020 Sep;50(3):287-290. doi: 10.4997/JRCPE.2020.315.
10
Pituitary dysfunction in granulomatosis with polyangiitis.肉芽肿性多血管炎的垂体功能障碍。
Pituitary. 2017 Oct;20(5):594-601. doi: 10.1007/s11102-017-0811-0.

引用本文的文献

1
A Rare Case of Microscopic Polyangitis With Associated Transient Hypophysitis.一例罕见的显微镜下多血管炎合并短暂性垂体炎病例。
JCEM Case Rep. 2025 Feb 13;3(3):luaf010. doi: 10.1210/jcemcr/luaf010. eCollection 2025 Mar.

本文引用的文献

1
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.利妥昔单抗与硫唑嘌呤维持治疗抗中性粒细胞胞质抗体相关性血管炎和复发性疾病患者的疗效比较:一项国际随机对照试验。
Ann Rheum Dis. 2023 Jul;82(7):937-944. doi: 10.1136/ard-2022-223559. Epub 2023 Mar 23.
2
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.EULAR 推荐的抗中性粒细胞胞浆抗体相关性血管炎治疗:2022 年更新。
Ann Rheum Dis. 2024 Jan 2;83(1):30-47. doi: 10.1136/ard-2022-223764.
3
2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis.
2022年美国风湿病学会/欧洲抗风湿病联盟巨细胞动脉炎分类标准。
Arthritis Rheumatol. 2022 Dec;74(12):1881-1889. doi: 10.1002/art.42325. Epub 2022 Nov 8.
4
Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis.利妥昔单抗、低剂量环磷酰胺联合血浆置换治疗重症抗中性粒细胞胞浆抗体相关性血管炎。
Kidney Int. 2021 Dec;100(6):1316-1324. doi: 10.1016/j.kint.2021.08.025. Epub 2021 Sep 22.
5
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.KDIGO 2021肾小球疾病管理临床实践指南。
Kidney Int. 2021 Oct;100(4S):S1-S276. doi: 10.1016/j.kint.2021.05.021.
6
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa.2021 年美国风湿病学会/血管炎基金会多发性大动脉炎管理指南。
Arthritis Rheumatol. 2021 Aug;73(8):1384-1393. doi: 10.1002/art.41776. Epub 2021 Jul 8.
7
Avacopan for the Treatment of ANCA-Associated Vasculitis.阿伐考潘治疗抗中性粒细胞胞浆抗体相关性血管炎。
N Engl J Med. 2021 Feb 18;384(7):599-609. doi: 10.1056/NEJMoa2023386.
8
Renal Involvement in Granulomatosis With Polyangiitis Increases Economic Health Care Burden: Insights From the National Inpatient Sample Database.显微镜下多血管炎的肾脏受累增加了医疗保健经济负担:来自国家住院样本数据库的见解
Cureus. 2021 Jan 5;13(1):e12515. doi: 10.7759/cureus.12515.
9
Primary pituitary granulomatosis with polyangiitis and the role of pituitary biopsy, case report and literature review.原发性垂体肉芽肿伴多血管炎及垂体活检的作用:病例报告及文献复习。
Br J Neurosurg. 2024 Apr;38(2):378-384. doi: 10.1080/02688697.2021.1878345. Epub 2021 Feb 4.
10
ANCA-associated vasculitis.抗中性粒细胞胞浆抗体相关性血管炎。
Nat Rev Dis Primers. 2020 Aug 27;6(1):71. doi: 10.1038/s41572-020-0204-y.